Pro-Calcitonin Levels Following Pediatric Cardiac Surgery

Completed

Conditions studied: Congenital Heart Disease, Sepsis, Infection

In brief

First, we, the researchers, hope to find out the PCT response to heart surgery in children by taking blood before surgery and each day for four days after surgery. These blood draws will help us figure out the typical Procalcitonin (PCT) response, the normal increase in PCT after heart surgery, and when the PCT level returns to baseline. Second, we, the researchers, hope to determine the accuracy of PCT as a marker of infection. Hypothesis Our hypothesis is that Procalcitonin is superior to other currently used markers of infection and will prove to be a clinically useful tool for evaluation of infection in children following cardiac surgery.

Key facts

Study ID

NCT00284570

Run by

Emory University

People needed

49

Starts

2006-01-01

Expected to finish

2007-03-01

Last updated by the study team

2013-11-27

Who can join

Age: any, up to 5. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with congenital heart disease
• Undergoing cardiopulmonary bypass and cardiac surgery
• Newborn (full term) to up to 6 years of age

You may not qualify if…

• Premature (less than 37 weeks)
• 6 years of age or older
• Intercurrent illness at time of surgery
• Orthotopic organ transplant recipient
• Pre-operative extra-corporeal support (ECMO)
• Acquired heart disease

Where it is running

• Children's Healthcare of Atlanta — Atlanta, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.